|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.60 EUR | -0.19% |
|
-3.35% | +35.80% |
| Aug. 04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| Aug. 03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 15.32B | |||||
| 1,057B | |||||
| 625B | - | - | - | ||
| 435B | |||||
| 363B | |||||
| 296B |
- Stock Market
- Stocks
- IPN Stock
- Charts Ipsen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
